BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 19230723)

  • 1. B lymphocytes exit lymph nodes through cortical lymphatic sinusoids by a mechanism independent of sphingosine-1-phosphate-mediated chemotaxis.
    Sinha RK; Park C; Hwang IY; Davis MD; Kehrl JH
    Immunity; 2009 Mar; 30(3):434-46. PubMed ID: 19230723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sphingosine-1-phosphate signalling-a key player in the pathogenesis of Angiotensin II-induced hypertension.
    Meissner A; Miro F; Jiménez-Altayó F; Jurado A; Vila E; Planas AM
    Cardiovasc Res; 2017 Feb; 113(2):123-133. PubMed ID: 28082452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-17-Producing Vγ4+ γδ T Cells Require Sphingosine 1-Phosphate Receptor 1 for Their Egress from the Lymph Nodes under Homeostatic and Inflammatory Conditions.
    Maeda Y; Seki N; Kataoka H; Takemoto K; Utsumi H; Fukunari A; Sugahara K; Chiba K
    J Immunol; 2015 Aug; 195(4):1408-16. PubMed ID: 26170380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of functional sphingosine-1 phosphate receptor-1 is reduced by B cell receptor signaling and increased by inhibition of PI3 kinase δ but not SYK or BTK in chronic lymphocytic leukemia cells.
    Till KJ; Pettitt AR; Slupsky JR
    J Immunol; 2015 Mar; 194(5):2439-46. PubMed ID: 25632006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gradients of the signaling lipid S1P in lymph nodes position natural killer cells and regulate their interferon-γ response.
    Fang V; Chaluvadi VS; Ramos-Perez WD; Mendoza A; Baeyens A; Rivera R; Chun J; Cammer M; Schwab SR
    Nat Immunol; 2017 Jan; 18(1):15-25. PubMed ID: 27841869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sphingosine 1-phosphate enhances the excitability of rat sensory neurons through activation of sphingosine 1-phosphate receptors 1 and/or 3.
    Li C; Li JN; Kays J; Guerrero M; Nicol GD
    J Neuroinflammation; 2015 Apr; 12():70. PubMed ID: 25880547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Vitro Characterization of Sphingosine 1-Phosphate Receptor 1 (S1P
    Schlicher L; Kulig P; von Münchow A; Murphy MJ; Keller MP
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monocyte-derived S1P in the lymph node regulates immune responses.
    Baeyens A; Bracero S; Chaluvadi VS; Khodadadi-Jamayran A; Cammer M; Schwab SR
    Nature; 2021 Apr; 592(7853):290-295. PubMed ID: 33658712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of S1P1 receptor surface expression by protein kinase C inhibition.
    Sensken SC; Gräler MH
    J Biol Chem; 2010 Feb; 285(9):6298-307. PubMed ID: 20032465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4
    García Nores GD; Ly CL; Cuzzone DA; Kataru RP; Hespe GE; Torrisi JS; Huang JJ; Gardenier JC; Savetsky IL; Nitti MD; Yu JZ; Rehal S; Mehrara BJ
    Nat Commun; 2018 May; 9(1):1970. PubMed ID: 29773802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical roles for Rac GTPases in T-cell migration to and within lymph nodes.
    Faroudi M; Hons M; Zachacz A; Dumont C; Lyck R; Stein JV; Tybulewicz VL
    Blood; 2010 Dec; 116(25):5536-47. PubMed ID: 20870900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SPNS2 enables T cell egress from lymph nodes during an immune response.
    Okuniewska M; Fang V; Baeyens A; Raghavan V; Lee JY; Littman DR; Schwab SR
    Cell Rep; 2021 Jul; 36(2):109368. PubMed ID: 34260944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An autophagy program that promotes T cell egress from the lymph node controls responses to immune checkpoint blockade.
    Houbaert D; Nikolakopoulos AP; Jacobs KA; Meçe O; Roels J; Shankar G; Agrawal M; More S; Ganne M; Rillaerts K; Boon L; Swoboda M; Nobis M; Mourao L; Bosisio F; Vandamme N; Bergers G; Scheele CLGJ; Agostinis P
    Cell Rep; 2024 Apr; 43(4):114020. PubMed ID: 38554280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired lymphocyte trafficking in mice deficient in the kinase activity of PKN1.
    Mashud R; Nomachi A; Hayakawa A; Kubouchi K; Danno S; Hirata T; Matsuo K; Nakayama T; Satoh R; Sugiura R; Abe M; Sakimura K; Wakana S; Ohsaki H; Kamoshida S; Mukai H
    Sci Rep; 2017 Aug; 7(1):7663. PubMed ID: 28794483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glia maturation factor-γ is involved in S1P-induced marginal zone B-cell chemotaxis and optimal IgM production to type II T-independent antigen.
    Li Y; Tang Y; Liu J; Meng X; Wang Y; Min Q; Hong R; Tsubata T; Hase K; Wang JY
    Int Immunol; 2022 Jan; 34(1):35-43. PubMed ID: 34673932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Get me out of here: Sphingosine 1-phosphate signaling and T cell exit from tissues during an immune response.
    Hallisey VM; Schwab SR
    Immunol Rev; 2023 Aug; 317(1):8-19. PubMed ID: 37212181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-10 Paradoxically Promotes Autoimmune Neuropathy through S1PR1-Dependent CD4
    Smith CJ; Allard DE; Wang Y; Howard JF; Montgomery SA; Su MA
    J Immunol; 2018 Mar; 200(5):1580-1592. PubMed ID: 29367208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A sphingosine-1-phosphate receptor 1 agonist inhibits tertiary lymphoid tissue reactivation and hypersensitivity in the lung.
    Huppé CA; Blais Lecours P; Lechasseur A; Gendron DR; Lemay AM; Bissonnette EY; Blanchet MR; Duchaine C; Morissette MC; Rosen H; Marsolais D
    Mucosal Immunol; 2018 Jan; 11(1):112-119. PubMed ID: 28422187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myo1g is required for efficient adhesion and migration of activated B lymphocytes to inguinal lymph nodes.
    Cruz-Zárate D; López-Ortega O; Girón-Pérez DA; Gonzalez-Suarez AM; García-Cordero JL; Schnoor M; Santos-Argumedo L
    Sci Rep; 2021 Mar; 11(1):7197. PubMed ID: 33785780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The critical role of Rap1-GAPs Rasa3 and Sipa1 in T cells for pulmonary transit and egress from the lymph nodes.
    Horitani S; Ueda Y; Kamioka Y; Kondo N; Ikeda Y; Naganuma M; Kinashi T
    Front Immunol; 2023; 14():1234747. PubMed ID: 37545505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.